Rhenman & Partners Asset Management AB Takes $1.77 Million Position in BrightSpring Health Services, Inc. $BTSG

Rhenman & Partners Asset Management AB purchased a new position in shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG) in the 3rd quarter, HoldingsChannel.com reports. The institutional investor purchased 60,000 shares of the company’s stock, valued at approximately $1,774,000.

Other large investors have also recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC purchased a new stake in BrightSpring Health Services in the 2nd quarter worth approximately $43,000. CWM LLC increased its stake in shares of BrightSpring Health Services by 105.3% in the third quarter. CWM LLC now owns 1,595 shares of the company’s stock worth $47,000 after acquiring an additional 818 shares during the last quarter. Amalgamated Bank raised its holdings in shares of BrightSpring Health Services by 62.7% during the third quarter. Amalgamated Bank now owns 3,041 shares of the company’s stock worth $90,000 after acquiring an additional 1,172 shares in the last quarter. Sandia Investment Management LP acquired a new stake in BrightSpring Health Services during the second quarter valued at $118,000. Finally, Penserra Capital Management LLC acquired a new stake in BrightSpring Health Services during the second quarter valued at $139,000.

BrightSpring Health Services News Summary

Here are the key news stories impacting BrightSpring Health Services this week:

• Positive Sentiment: Zacks added BTSG to its Zacks Rank #1 (Strong Buy) growth list for March 6, highlighting it as a top growth pick. Best Growth Stocks to Buy for March 6th
• Positive Sentiment: Zacks similarly featured BTSG on its March 5 list of best growth / strong-buy stocks, reinforcing buy-side attention across consecutive days. Best Growth Stocks to Buy for March 5th
• Positive Sentiment: Zacks upgraded BTSG from Hold to Strong Buy and published follow-ups pointing to momentum and rising earnings estimate revisions—signals that analysts are lifting near?term expectations. Zacks.com upgrade
• Positive Sentiment: Zacks published a piece noting surging earnings estimate revisions for BTSG, which is commonly bullish for the stock if revisions translate into higher forward EPS and investor expectations. Surging Earnings Estimates Signal Upside
• Positive Sentiment: Broker commentary (Mizuho) and media noted strong price-appreciation forecasts and heavy trading after the analyst upgrade, which can support further upside if momentum continues. Mizuho Forecasts Strong Price Appreciation Sees Strong Trading Volume After Analyst Upgrade
• Neutral Sentiment: Zacks published comparative coverage showing how BTSG stacks up vs. medical peers this year—useful context but not an immediate catalyst. Peer Performance
• Neutral Sentiment: Reported short-interest figures in the dataset show 0 shares and 0.0 days-to-cover (likely a data artifact). That suggests no clear short-position signal from the reported data and should be treated cautiously.
• Negative Sentiment: Fundamentals remain mixed: the company’s most recent quarterly report showed strong revenue growth but a small EPS miss and the stock trades at a elevated PE, which can make it vulnerable to short-term pullbacks despite positive analyst notes.

Insider Transactions at BrightSpring Health Services

In other news, insider Lisa A. Nalley sold 30,000 shares of the firm’s stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $41.15, for a total value of $1,234,500.00. Following the sale, the insider owned 110,594 shares in the company, valued at approximately $4,550,943.10. This trade represents a 21.34% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Jon B. Rousseau sold 220,000 shares of the business’s stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $41.15, for a total transaction of $9,053,000.00. Following the transaction, the insider directly owned 1,023,880 shares in the company, valued at $42,132,662. This trade represents a 17.69% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 285,000 shares of company stock worth $11,727,750 over the last three months. 3.40% of the stock is currently owned by insiders.

BrightSpring Health Services Trading Down 0.7%

Shares of NASDAQ:BTSG opened at $41.49 on Friday. The company has a debt-to-equity ratio of 1.32, a quick ratio of 1.12 and a current ratio of 1.57. The stock’s 50-day moving average is $39.50 and its 200-day moving average is $33.98. The company has a market cap of $8.03 billion, a P/E ratio of 47.15, a P/E/G ratio of 0.55 and a beta of 2.31. BrightSpring Health Services, Inc. has a 52-week low of $15.48 and a 52-week high of $44.87.

BrightSpring Health Services (NASDAQ:BTSG) last posted its quarterly earnings data on Friday, February 27th. The company reported $0.33 earnings per share for the quarter, missing the consensus estimate of $0.34 by ($0.01). BrightSpring Health Services had a return on equity of 12.66% and a net margin of 1.48%.The business had revenue of $3.55 billion for the quarter, compared to analyst estimates of $3.38 billion. During the same period in the prior year, the firm posted $0.11 EPS. BrightSpring Health Services’s revenue for the quarter was up 29.3% on a year-over-year basis. Equities research analysts predict that BrightSpring Health Services, Inc. will post 0.59 earnings per share for the current year.

Wall Street Analyst Weigh In

Several brokerages have weighed in on BTSG. Bank of America upped their target price on BrightSpring Health Services from $38.00 to $41.00 and gave the stock a “buy” rating in a research report on Tuesday, December 9th. BTIG Research reiterated a “buy” rating and set a $55.00 price target on shares of BrightSpring Health Services in a report on Monday, March 2nd. Wall Street Zen cut BrightSpring Health Services from a “strong-buy” rating to a “buy” rating in a research note on Saturday, November 15th. Mizuho increased their price objective on BrightSpring Health Services from $45.00 to $50.00 and gave the stock an “outperform” rating in a report on Tuesday, March 3rd. Finally, BMO Capital Markets reaffirmed an “outperform” rating and set a $46.00 price objective on shares of BrightSpring Health Services in a research report on Friday, January 23rd. Two analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $44.08.

About BrightSpring Health Services

BrightSpring Health Services (NASDAQ: BTSG) is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company’s operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.

Through its network of subsidiary brands, BrightSpring offers integrated care in the patient’s home environment, fostering independence and improving quality of life.